Brexpiprazole Impurity 42
✓
データの正確性100%
24時間年中無休の科学サポート
⬡
品質に対する妥協ゼロ

在庫拠点

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート(SER)、および製品に応じた追加分析データ。

Brexpiprazole Impurity 42

● 在庫あり

カタログ番号:VE0025313
CAS番号:N/A
分子式:C25H27N3O3
分子量:417.50 g/mol

に関する追加情報 Brexpiprazole Impurity 42

親薬物

Brexpiprazole

IUPAC名

7-(4-(4-(benzofuran-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one

薬局方同義語

N/A

Other Synonyms

N/A

SMILES

O=C(C=C1)NC2=C1C=CC(OCCCCN(CC3)CCN3C4=CC=CC5=C4C=CO5)=C2

InChI

InChI=1S/C25H27N3O3/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10, 17-18H, 1-2, 11-16H2, (H, 26, 29)

説明

Brexpiprazole Impurity 42 is a characterized process-related impurity detected in Brexpiprazole batches with low-level presence in the impurity profile. Analytical data indicate retention behavior consistent with a moderately polar degradation or synthetic byproduct | resolved by reversed-phase HPLC and confirmed by LC-MS and high-resolution mass spectrometry. Structural elucidation by NMR suggests substitution pattern variants of the parent scaffold | potentially affecting potency and safety margins if uncontrolled. Risk-based control strategies include validated chromatographic methods | specification limits | forced-degradation studies | and targeted purification steps to mitigate formation. Routine monitoring in stability and release testing ensures regulatory compliance and product quality assurance.

見積もり依頼

「*」は必須フィールドを示します

このフィールドは入力チェック用です。変更しないでください。
Products quotation
Name
Url